FAK/PTK2 expression is associated positively with KDR in KIRC, and negatively with PVRL2 in TGCT, HAVCR2, and PDCD1LG2 in BLCA (Fig. 7). The gene discussed is PTK2; the disease is bladder transitional cell carcinoma.